Revenue: The sum of all revenue fields included for a company's operating activities.
Dianthus Therapeutics, Inc. (DNTH) had Revenue of $0.46M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$0.46M |
$-40.83M |
|
-- |
|
$0.46M |
|
$47.00M |
|
$-46.53M |
|
$5.70M |
|
$-40.83M |
|
$-40.53M |
|
$-40.83M |
|
$-40.83M |
|
$-40.83M |
|
$-40.53M |
|
$-46.53M |
|
$-47.67M |
|
48.03M |
|
48.03M |
|
$-0.85 |
|
$-0.85 |
|
| Balance Sheet Financials | |
$1.12B |
|
$0.27M |
|
$126.97M |
|
$1.25B |
|
$38.28M |
|
-- |
|
$7.29M |
|
$45.57M |
|
$1.20B |
|
$1.20B |
|
$1.20B |
|
54.58M |
|
| Cash Flow Statement Financials | |
$-28.86M |
|
$-133.97M |
|
$739.41M |
|
$51.25M |
|
$627.84M |
|
$576.58M |
|
$10.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
29.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-10050.32% |
|
-10050.32% |
|
-- |
|
-8819.44% |
|
-8819.44% |
|
$-28.87M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.38 |
|
239.09 |
|
-3.40% |
|
-3.40% |
|
-3.27% |
|
-3.40% |
|
$22.01 |
|
$-0.60 |
|
$-0.60 |
|